Page last updated: 2024-10-22

ampiroxicam and Carcinoma, Mucoepidermoid

ampiroxicam has been researched along with Carcinoma, Mucoepidermoid in 1 studies

ampiroxicam: prodrug of piroxicam; structure given in first source
ampiroxicam : A benzothiazine that is the 1-[(ethoxycarbonyl)oxy]ethyl ether of piroxicam. A prodrug for piroxicam, it is used for the relief of pain and inflammation in musculoskeletal disorders such as rheumatoid arthritis and osteoarthritis.

Carcinoma, Mucoepidermoid: A tumor of both low- and high-grade malignancy. The low-grade grow slowly, appear in any age group, and are readily cured by excision. The high-grade behave aggressively, widely infiltrate the salivary gland and produce lymph node and distant metastases. Mucoepidermoid carcinomas account for about 21% of the malignant tumors of the parotid gland and 10% of the sublingual gland. They are the most common malignant tumor of the parotid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575; Holland et al., Cancer Medicine, 3d ed, p1240)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, KH1
Shim, JH1
Huong, LD1
Cho, NP1
Cho, SD1

Other Studies

1 other study available for ampiroxicam and Carcinoma, Mucoepidermoid

ArticleYear
Inhibition of myeloid cell leukemia-1 by tolfenamic acid induces apoptosis in mucoepidermoid carcinoma.
    Oral diseases, 2011, Volume: 17, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Mucoepidermoid; Caspase 3; Cell Nucl

2011